Since the APA's last report on tardive dyskinesia in 1979, considerable research has been conducted on the prevalence, incidence, and risk factors associated with the development of late-occurring neuroleptic side effects. This book summarizes the progress made over the last decade in understanding the differential diagnosis and epidemiology of tardive dyskinesia, as well as risk factors, course, and treatment.
The reader will benefit from the book's coverage of

• indications for neuroleptic use
  
• alternative maintenance strategies
  
• factors to consider in making a differential diagnosis
  
• frequently encountered problems in dealing with special populations such as children and mentally retarded people
  
• clinical-legal issues related to tardive dyskinesia
  
• clearly specified recommendations for prevention and management